Serum macrophage inflammatory protein-1α and high-sensitivity C-reactive protein in patients with obstructive sleep apnea-hypopnea syndrome and hypertension
|更新时间:2026-01-09
|
Serum macrophage inflammatory protein-1α and high-sensitivity C-reactive protein in patients with obstructive sleep apnea-hypopnea syndrome and hypertension
Journal of Army Medical UniversityVol. 32, Issue 7, Pages: 696-699(2010)
Zhang Nan,Qin Shu,Zhang Dongying,Yang Yiping,Deng Qiongzhen,You Xiaojun.Serum macrophage inflammatory protein-1α and high-sensitivity C-reactive protein in patients with obstructive sleep apnea-hypopnea syndrome and hypertension[J].J Amry Med Univ (J Third Mil Med Univ),2010,32(07):696-699.
Zhang Nan,Qin Shu,Zhang Dongying,Yang Yiping,Deng Qiongzhen,You Xiaojun.Serum macrophage inflammatory protein-1α and high-sensitivity C-reactive protein in patients with obstructive sleep apnea-hypopnea syndrome and hypertension[J].J Amry Med Univ (J Third Mil Med Univ),2010,32(07):696-699.DOI:
Serum macrophage inflammatory protein-1α and high-sensitivity C-reactive protein in patients with obstructive sleep apnea-hypopnea syndrome and hypertension
Objective To identify the effects of obstructive sleep apnea-hypopnea syndrome (OSAHS) on serum levels of macrophage inflammatory protein-1α (MIP-1α) and high-sensitivity c-reactive protein (hs-CRP)
and impact on cardiac structure and function in patients with hypertension (HT). Methods Polysomnography (PSG) was employed to determine OSAHS
and HT was verified by cardiovascular methods. Totally 86 middle-aged subjects admitted in our hospital from April to December 2008 were classified into 4 groups according to the absence or presence of OSAHS and with or without HT
OSAHS patients without HT (OSAHS group
n=29)
OSAHS patients with HT (OSAHS+HT group
n=27)
non-OSAHS patients with HT (HT group
n=27)
and health volunteers without OSAHS or HT (control subjects
n=27). OSAHS patients were divided into mild
moderate and severe degree based on apnea hypopnea index (AHI). All participants underwent polysomnography and echocardiography. Serum MIP-1α and hs-CRP levels were tested by enzyme linked immunosorbent assay (ELISA). Results Systolic
diastolic blood pressure (SBP
DBP) and pulse pressure difference (PP) in HT group and OSAHS+HT group were significantly higher than those in OSAHS group. Comparing with control group
the E velocity (EV) was significant decreased and A velocity (AV) was increased significantly in OSAHS
OSAHS+HT and HT groups (P0.05). Serum MIP-1α levels in OSAHS+HT group was significant higher than HT groups (P0.05). Serum MIP-1α levels in those 3 groups were negatively correlated with AV (r=-0.238
P=0.08) and positively correlated with E/A ratio (r=0.307
P=0.02). Conclusion We have not found the cardiac systolic function change in early OSAHS patients with HT
while the diastolic function is decreased obviously. Serum MIP-1α level shows earlier change than hs-CRP level in OSAHS patients
which may contribute to the lesion of cardiac diastolic function.